As a resource to visitors of the Alzheimer Europe Website, we will include videos of the keynote, plenary presentations and symposia at the Alzheimer Europe Conference in Barcelona.

Videos from the following speakers will be included:

Welcome and introductory comments by

• Iva Holmerová, Chairperson, Alzheimer Europe
• Cheles Cantabrana, Chairperson, CEAFA
• Santiago Marimón Suñol (Spain)
• Gemma Tarafa, Commissioner for Health, Barcelona City Council

and a keynote lecture from:

• José Luis Molinuevo (Spain): Will we be able to prevent Alzheimer’s disease?

Plenary sessions:

• Meet the researchers of tomorrow: Anja Leist (Luxembourg): Policy and research priorities of the WYLD (World Young Leaders in Dementia) network
• Carmen Orte (Spain): Dementia as a health and social priority in Spain
• Geoff Huggins (United Kingdom): The European Joint Action on Dementia: Identifying and sharing good practices across Europe
• Dan Chisholm (WHO Europe): Prioritising dementia internationally - The WHO Global Action Plan on Dementia and the Global Dementia Observatory
• John Gallacher (United Kingdom): Real world data supporting regulatory and health technology assessments: the findings of the ROADMAP project
• Meet the researchers of tomorrow: Stina Saunders (United Kingdom): Involving research participants in research: The example of the EPAD (European Prevention of Alzheimer’s dementia) project
• Helen Rochford-Brennan (Ireland): Promoting a human rights based approach to dementia through the active involvement of people with dementia
• Fernando Vicente (Spain): Human rights in Spanish health and social legislation
• Dianne Gove (Luxembourg): Recognising dementia as a disability: ethical considerations and practical recommendations
• Karen Watchman (United Kingdom): Dementia and intellectual disability - Valuing the perspectives of people with intellectual disability
• Meet the researchers of tomorrow: Sébastien Libert (Belgium): Assistive technologies in dementia: Findings of the INDUCT (Interdisciplinary Network for Dementia Using Current Technology) consortium
• Gail Mountain (United Kingdom): Redefining and measuring meaningful outcomes for people with dementia
• Manuel Martín Carrasco (Spain): Reducing the use of antipsychotics in residential and nursing homes
• Martina Roes (Germany): Fostering and sustaining relationships with people with dementia
• Meet the researchers of tomorrow: Isadora Alves Lopes (Netherlands): The AMYPAD (Amyloid imaging to prevent Alzheimer’s disease) project: Improving our understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging
• María Isabel González Ingelmo (Spain): Importance of social and health care research in the field of Alzheimer’s disease and other dementias
• Mercè Boada (Spain): Improving the diagnosis of Alzheimer’s disease through EU research collaborations
• Philippe Amouyel (France): Genetics of Alzheimer’s disease, a state-of-play
• Clive Ballard (United Kingdom): What pharmacological options for the treatment of behavioural symptoms of dementia?

Special Symposia:

• Mercè Boada (Spain): MOPEAD
• Octavio Rodríguez Gómez (Spain): MOPEAD
• Adrián Rodrigo Salas (Spain): MOPEAD
• Octavio Rodríguez Gómez (Spain) (2): MOPEAD
• Andreea Ciudin (Spain): MOPEAD
• Annette Dumas (Belgium): MOPEAD
• Petri Lampinen (Finland): The experience of receiving a diagnosis of frontotemporal dementia
• The European Working Group of People With Dementia: I have dementia and life goes on
• Thomas Rune Nielsen (Denmark): The prevalence, assessment and diagnosis of dementia in minority ethnic groups
• Charlotta Plejert (Sweden): Interpreter-mediated dementia assessments of people from minority ethnic groups
• Mohammed Akhlak Rauf (United Kingdom): Working with and involving local minority ethnic groups in the development of intercultural care and support
• Debi Lahav (Israel): Activities and support for people from minority ethnic groups provided by the Alzheimer Association of Israel
• Michal Herz (Israel): Issues surrounding live-in/migrant carers for people with dementia

ROADMAP parallel sessions:

• Claire Tochel (United Kingdom): Outcome definition in ROADMAP
• Christophe Bintener (Luxembourg) and a representative of the EWGPWD: The involvement of the European Working Group of People with Dementia in the outcomes work of ROADMAP
• Michael Smith (United Kingdom): Important outcomes of Alzheimer’s disease from the perspective of people with the disease, their supporters & health professionals
• Tania Dussey (Switzerland): Reflections on ROADMAPs outcome definition work
• Ana Diaz (Luxembourg) and a representative of the EWGPWD: The involvement of the European Working Group of People With Dementia in the ethics work of ROADMAP
• Zuzanna Angehrn (Switzerland): Ethical and social implications of using predictive modelling for Alzheimer´s disease prevention
• Alex Mckeown (United Kingdom): Ethical issues in outcome prioritisation in Alzheimer’s disease treatment
• Diane O’Rourke (United Kingdom): Regulatory and HTA perspectives on real-world data in Alzheimer’s Disease
• Catherine Reed (United Kingdom): Learnings from ROADMAP - what is next?
• Glòria Garcia (Spain): Developing the Data Cube
• Johan van der Lei (Netherlands): Challenges to fill in the Data Cube, differences across data sources
• Antje Hottgenroth (Germany): Industry perspective on use and future development

Closing comments and farewell by:

• Nohemi Martínez Rodriguez, Vice-President, Fundación Alzheimer España
• Cheles Cantabrana, Chairperson, CEAFA
• Iva Holmerová, Chairperson, Alzheimer Europe